Results 241 to 250 of about 3,617,077 (391)

Assessment of Appropriate Prescribing in Maintenance Haemodialysis and Comparison of Prescribing Patterns Between State- and Privately-Funded Patients: A Retrospective Review. [PDF]

Hosp Pharm
Kampanza M, Verbeeck RK, Jonkman L, Mubita M.   +3 more
europepmc   +1 more source

Precision medicine

Brazilian Journal of Otorhinolaryngology, 2018
openaire   +3 more sources

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Equitable access to essential medicines to treat neglected tropical diseases: Latest developments from the World Health Organization (WHO). [PDF]

PLoS Negl Trop Dis
Fattah F, Lester R, Kalua K, Sharp B, Wasan KM.   +4 more
europepmc   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Barriers to accessing high-quality cancer medicines in Cameroon. A qualitative study of the views and practices of regulators and frontline healthcare providers. [PDF]

PLOS Glob Public Health
Saidu Y, Makia MC, Frambo A, Nang AN, Mulu A, Ashenef A, Benyam M, Chikowe I, Pastakia SD, Higgins CR, Paul N, Lieberman M.   +11 more
europepmc   +1 more source

Herbal medicines in the treatment of psychiatric disorders: 10‐year updated review

Phytotherapy Research, 2018
J. Sarris
semanticscholar   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Changes to the use of medicines containing the antibiotic azithromycin. [PDF]

Fam Med Community Health
Ruepp R, Botgros R, Le Ber V, Brandt F, Pantke E, Fuerst-Wilmes M, Gomez-Outes A, Fernandez-Cortizo MJ.   +7 more
europepmc   +1 more source

Agricultural medicine [PDF]

Journal of Occupational Accidents, 1979
openaire   +3 more sources